The F/m Emerald Life Sciences Innovation ETF (LFSC) top stock holdings include Travere Therapeutics, Cogent Biosciences, and Spyre Therapeutics. The top 25 LFSC holdings ordered by weight make up 91.27% of the total fund. LFSC is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete LFSC stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.
Top 25 LFSC Holdings
LFSC Geographic Exposure
LFSC's largest geographic exposure is United States at 184.3%, followed by United Kingdom at 13.2%.
LFSC Currency Exposure
LFSC is exclusively exposed to USD.
LFSC Sector Exposure
LFSC's largest sector exposure is Health Care at 160.5%, followed by Consumer Discretionary at 11.1%.
LFSC Industry Exposure
LFSC's largest industry exposure is Biotechnology at 119.9%, followed by Health Care Equipment & Supplies at 27.7%.
Health Care Equipment & Supplies
Diversified Consumer Services
Health Care Providers & Services
LFSC Sub-Industry Exposure
LFSC's largest sub-industry exposure is Biotechnology at 112.4%, followed by Health Care Equipment at 27.7%.